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T-cell activation is a complex process crucial for a proper function of immune system. It has 
been extensively studied and its main features are well understood. However, some of the 
events involved in T-cell signalling are still unclear. After T-cell receptor stimulation, Src-
family kinase Lck drives the initiation of signalling by tyrosine phosphorylation. 
Phosphorylation of several downstream targets is dependent on the redistribution of Lck to 
the different compartment of the plasma membrane, called lipid rafts. In lipid rafts, active 
Lck is juxtaposed and activates raft-resident substrates which then trigger downstream 
signalling. The critical in this process is the mechanism of Lck translocation to lipid rafts 
which has not been studied so far and represents the topic of great academic and clinical 
interests. Previously, we identified the adaptor protein RACK1 as a candidate protein 
mediating the redistribution of Lck to lipid rafts by linking it to the microtubular network. In 
this thesis, we analysed the structural features and functional role of RACK1 in its interaction 
with Lck. We show here, using the SYF cell lines expressing the wild type and various 
mutated forms of Lck, that intact SH3 or SH2 domains of Lck are required for an effective 
RACK1-Lck complex formation. We also documented a mild, but reproducible and sequence-
specific effect of the C-terminal end of Lck in this process. This indicates that both SH2 and 
SH3 domains of Lck play a critical role in the complex formation with RACK1. The 
immunoprecipitation of SH3 and SH2 domains with RACK1 from lysates of transfected cells 
and cell-free in vitro translation system failed to detect their direct binding. This suggests 
that this interaction could be indirect and mediated by other proteins. Several such 
candidate proteins involved in the RACK1-Lck complex formation has been identified and 
one of them, the adaptor protein GADS, was tested as a possible linker between RACK1 and 
Lck. Adenovirus-induced overexpression of gene expression of RACK1 was used to assess its 
physiological role during the early onset of TCR signalling in primary T-cells. While these 
technically difficult experiments were completed, viral infection induced high levels of non-
specific activation of T-cells and prevented us from a direct observation of influence of 
RACK1 overexpression on their activation. To circumvent these conditions, we prepared and 
successfully tested all reagents necessary for the downregulation of RACK1 by RNA 
interference. This alternative approach will be used in the near future for the functional 
characterisation of RACK1 in T-cell activation. Together, our data identified structural 
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elements of Lck involved in RACK1-Lck complex formation and provided insight into the 
composition of this complex. During this work, we also prepared all necessary molecular, 
cellular and organismal reagents to assess the role of RACK1 in the redistribution of Lck 
during early phases of T-cell activation.  
 
Keywords: Lck, T-cell, lipid rafts, RACK1, GADS, T-cell activation  
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2. Abstrakt (CZ) 
 
Aktivace T-lymfocytů je složitý proces zcela zásadní pro správnou funkci imunitního 
systému. Jako takový byl v minulosti důkladně zkoumán a jeho základní rysy jsou velmi 
dobře popsány. Neplatí to ovšem pro všechny události, které během T-buněčné 
signalizace nastávají. Po stimulaci T-buněčného receptoru kináza Lck z rodiny Src 
zajišťuje spuštění signalizace fosforylací tyrosinů. Fosforylace dalších proteinů je závislá 
na přesunutí Lck do jiných kompartmentů plazmatické membrány, takzvaných lipidových 
raftů. V lipidových raftech je Lck v blízkosti svých substrátů, které a aktivuje a které 
následně spouští další signalizaci. Kritickou částí tohoto procesu je translokace Lck do 
lipidových raftů, jejíž mechanismus zůstává dosud neprozkoumaný, a jako takový je 
objektem značného akademického i klinického zájmu. Již dříve jsme identifikovali 
adaptorový protein RACK1 jakožto kandidátní protein zprostředkovávající redistrubuci 
Lck do lipidových raftů pomocí propojení Lck s mikrotubulární sítí. V této práci jsme 
analyzovali strukturní znaky a funkci RACK1 v interakci s Lck. S využitím buněčných linií 
SYF exprimující buď přirozené nebo různě mutované formy Lck zde ukazujeme, že plně 
funkční SH3 a SH2 domény Lck jsou nezbytné pro efektivní vytvoření komplexu 
RACK1-Lck. Také jsme zjistili malý, ale reprodukovatelný a sekvenčně specifický vliv 
C-terminální domény Lck na tento proces. Tato zjištění naznačují, že SH2 i SH3 domény 
Lck hrají zásádní roli v tvorbě komplexu s RACK1. Nepodařilo se nám imunoprecipitací 
SH2 a SH3 domén s RACK1 z lyzátů transfekovaných buněk a z bezbuněčného in vitro 
translačního systému detekovat jejich přímou vazbu. To naznačuje, že interakce by 
mohla být nepřímá a zprostředkovaná dalšími proteiny. Identifikovali jsme několik 
kandidátních proteinů pro tuto roli, které se účastní formování RACK1-Lck komplexu. 
Jeden z nich, adaptorový protein GADS, byl testován jako možné pojítko mezi RACK1 a 
Lck. Overexprese genu RACK1 indukovaná adenovirem byla využita k objasnění 
fyziologické role tohoto proteinu během počínající signalizace přes TCR v primárních T-
lymfocytech. Během dokončování těchto technicky náročných experimentů způsobovala 
virová infekce vysokou úroveň nespecifické aktivace T-buněk, což nám znemožnilo 
pozorovat vliv nadměrné exprese RACK1 na jejich aktivaci. Abychom obešli tyto 
problémy, připravili jsme a úspěšně otestovali reagencie nezbytné pro snížení množství 
RACK1 v buňkách pomocí RNA interference. Tento alternativní přístup bude v blízké 
budoucnosti použit ke zkoumání vlivu RACK1 na aktivaci T-lymfocytů. Společně naše 
data ukázaly strukturní části Lck využívané při utváření komplexu RACK1-Lck a poskytly 
nové informace o jeho dalších složkách. Během této práce jsme taktéž připravili veškeré 
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molekulární, buněčné a organismální reagencie potřebné ke zkoumání role RACK1 
v redistribuci Lck během časné aktivace T-lymfocytů. 
3.  





5. List of Abbreviations 
 
AP-1 Activator protein 1 
APC Antigen presenting cell 
Arp2/3 Actin related protein 2/3 
ATP Adenosine triphosphate 
Bcl-XL B-cell lymphoma – extra large 
Blk B lymphocyte kinase 
cAMP Cyclic adenosine monophosphate 
CAR Coxsackie/adenovirus receptor 
Cbp/PAG Csk binding protein/protein associated with 
glycosphingolipid-enriched microdomains 
CDC42 Cell division control protein 42 
Csk C-terminal Src kinase 
CTLA4 Cytotoxic T-lymphocyte-associated protein 4 
DAG Diacyl glycerol 
DPC Distal pole complex 
EBP50 ERM binding protein 50 
EGF Epidermal growth factor 
EGFP Enhanced green fluorescent protein 
eIF6 Eukaryotic translation initiation factor 6 
Erk Extracellular signal-regulated kinase 
ERM Erzin, radixin, moesin protein family 
FACS Fluorescence-activated call sorting 
F-actin Filamentous actin 
FAK Focal adhesion kinase 
Fgr Gardner-Rasheed feline sarcoma viral (v-fgr) 
oncogene homolog 
GABA Gamma-aminobutyric acid 
GADS GRB2-related adapter protein 2 
GDP Guanosine diphosphate 
GEF Guanine nucleotide exchange factor 
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GFP Green fluorescent protein 
GRB2 Growth factor receptor-bound protein 2 
GST Glutathione S-transferase 
GTP Guanosine triphosphate 
HA Hemagglutinin 
ICOS Inducible T-cell costimulator 
ICOSL Inducible T-cell costimulator ligand 
IKK IκB kinase 
IL-2 Interleukin 2 
IL-7 Interleukin 7 
IP3 Inositol-1,4,5-triphosphate 
IRES Internal ribosome entry site 
IS Immunological synapse 
ITAM Immunoreceptor tyrosine-based activation 
motif 
Itk Interleukin-2-inducible T-cell kinase 
IκB Inhibitor on NFκB 
JNK c-Jun N-terminal kinase 
LASP LIM and SH3 domain protein 1 
LAT Linker of activated T-cell 
Lck Lymphocyte-specific kinase 
LFA-1 Lymphocyte function-associated antigen 1 
MAP kinase Mitogen-activated protein kinase 
MEK MAP/Erk kinase 
MHC Major histocompatibility complex 
MOI Multiplicity of infection 
MS Mass spectrometry 
MTOC Microtubule organizing centre 
Nck Non-catalytic region of tyrosine kinase adaptor 
protein 1 
NFAT Nuclear factor of activated T-cells 
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NFκB Nuclear factor kappa-light-chain-enhancer of 
activated B cells 
NMDAR N-methyl-D-aspartate receptor 
PD1 Programmed cell death protein 1 
PDK1 3-phosphoinositide dependent protein kinase-1 
PD-L1 Programmed cell death protein ligand 1 
PH Pleckstrin homology domain 
PI3K Phosphatidylinositol-4,5-bisphosphate 3-kinase 
PIP2 Phosphatidylinositol-4,5-bisphosphate 
PIP3 Phosphatidylinositol-(3,4,5)-trisphosphate 
PKC Protein kinase C 
PLCγ1 Phospholipase C 
pMHC peptide-MHC complex 
PSGL-1 P-selectin glycoprotein ligand-1 
Rac1 Ras-related C3 botulinum toxin substrate 1 
RACK1 Receptor for activated C-kinase 
Ras Rat sarcoma protein 
RasGRP RAS guanyl nucleotide-releasing protein 1 
SFK Src family kinase 
SH1, SH2, SH3 Src homology domain 1, 2, 3 
shRNA Small hairpin RNA 
SLP-76  SH2 domain containing leukocyte protein of 
76kDa 
SMAC (cSMAC, pSMAC, dSMAC) Supramolecular activation cluster (central, 
peripheral, distal) 
Sos Son of sevenless 
SYK Spleen tyrosine kinase 
TCR T-cell receptor 
TLR Toll-like receptor 
WASP Wiskott–Aldrich Syndrome Protein 
WAVE2 WASP-family verprolin-homologous protein 2 
WB Western blotting 
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WT Wild type 
Yes Yamaguchi sarcoma viral (v-yes) oncogene 
homolog 1 







Immune system is a crucial mechanism that protects life of every organism, in one form 
or another.   It protects us from pathogens as well as harmful processes of our own bodies. 
Immunity is traditionally divided into two parts, innate and adaptive. Innate is evolutionally 
older and is generally considered non-specific, while adaptive is induced by a specific 
molecule and is ready to recognise virtually endless range of antigens. These two parts are 
not independent, but tightly interconnected and even indispensable for proper function of 
each other.  
Important part of adaptive immunity are T-cells. Their receptors are highly variable and T-
cells are therefore able to recognise immense number of antigens. During their lives, they 
have to be able to react to various stimuli in a correct manner. For this purpose they employ 
numerous ways of signalling. Whether they mature, migrate, detect invaders, secret 
cytokine or kill pathogens, they always convey relevant signals to the nucleus to modulate 
their genetic program to adapt to a changing microenvironment and to communicate with 
other immune cells.  
When T-cell recognises an antigen, it is activated and consequently orchestrates and 
performs immune response to danger. T-cell activation is a complex process engaging 
multiple signalling pathways. To achieve an unencumbered coordination, specificity and 
efficiency in signalling, the process requires physical segregation of signalling elements into 
appropriate confinement. The initial processes take place on the plasma membrane. T-cell 
receptor delivers a signal of recognition of antigen, which is further transmitted by protein 
tyrosine kinase Lck. Lck-induced phosphorylation leads to engagement of a cohort of other 
proteins, which leads to triggering of various signalling pathways. 
In spite of the fact that the process of T-cell activation has been studied for decades and 
schematics of T-cell signalling are well understood, some crucial details are still obscure. The 
mechanism of Lck engagement in first moments after T-cell receptor stimulation is 
undescribed. It has been proposed that it is caused by change of localisation on the 
membrane, but its precise mechanism is still unknown. In this thesis, we tried to elucidate 





7. Literature review 
 
This section summarises the information about the T-cell signalling. It describes pathways 
engaged during the initial stage of T-cell activation. It also introduces several currently 
considered models of T-cell activation and signal transduction from the TCR inside the cell. 
Furthermore, it highlights s the structure and mechanisms of regulation of Lck, the member 
of Src-family tyrosine kinases (SFKs), which generates the first detectable signal after T-cell 
activation and is absolutely critical for the initiation of TCR signalling. And finally, it describes 
structure and function of receptor for activated C-kinase, an adaptor protein which could 
play so far undescribed, but important role in the proximal T-cell signalling by regulating the 
subcellular redistribution of Lck. 
 
7.1. T-cell signalling 
 
T-cells are crucial part of the adaptive immune system, highly efficient and extremely 
versatile. To ensure that they only response to potentially dangerous stimuli derived from 
pathogens, a complex mechanism of activation is employed. The engagement of TCR starts a 
rapid response leading to a lasting change in the behaviour of T-cell. To ensure the activation 
occurs under proper conditions and to avoid autoimmunity, T-cells require two separate 
signals from the antigen presenting cell (APC): (i) specific signal generated upon peptide-
MHC-TCR interaction (Norcross, 1984) and (ii) costimulatory signal via CD28-CD80/86 
interaction (Lenschow et al., 1996). If both signals are delivered in appropriate spatio-
temporal fashion, the process of T-cell activation is initiated. We can distinguish three stages 
of this process (Mempel et al., 2004). The initial phase starts by forming very short and 
temporary associations of T-cells with APCs in secondary lymphoid organs, whereby T-cell 
scans the surface of APC for cognate agonist peptide-MHC complexes. If successful and such 
interaction is productive, the most proximal signalling event is triggered. When this initial 
phase is completed, in the second phase, the interacting cells form a stable conjugates and 
the close apposition of their membranes forms a visually distinguishable structure called the 
immunological synapse (IS) (Grakoui et al., 1999). IS is a highly complex and dynamic 
arrangement of crucial signalling molecules and their complexes which are recruited and 
transiently harboured to this confined space in order to further drive the progression of T 
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cell activation process. The outcome of this early activation event is the expression of early 
activation markers CD69 and CD44 as well as the expression of CD25 (α-chain of IL-2 
receptor). 24 hrs after, if the interaction persists, the third stage takes place during which 
conjugated cells dissociate, T-cells start to produce IL-2 and proliferate. 
 
7.1.1. T-cell triggering 
 
T-cell activation relies on the recognition of a peptide displayed in the context of MHC. 
There are two major subtypes of MHC, class I and II, both recognized simultaneously by TCR 
and a coreceptor, CD8 or CD4, respectively. MHC class I is expressed on all cell types and 
presents peptides from endogenous proteins. Its expression serves as a hallmark of healthy 
cells and their resident tissues. After infection, such as viral transmission, intracellular 
pathogen-derived peptides are copresented with normal endogenous proteins in the context 
of MHCI, enabling CD8+ T-cells to identify and eliminate infected cells. MHC class II proteins 
are expressed mainly on APCs and serve for the presentation of peptides derived from 
extracellular proteins, thus sampling the surrounding environment. APCs internalize and 
enzymatically process these antigens in the endolysosomal compartment and resulting 
peptides are loaded on MHC class II. Consequently, the peptide-MHCII complexes can be 
recognized by cognate CD4+ T-cells. (Vyas et al., 2008) 
The recognition is mediated by TCR complex, consisting of α and β chain of TCR and γ, δ, 
two ε and two ζ chains of CD3. Simultaneously, MHCII is recognised by CD4 coreceptor (or by 
CD8 in case of MHC class I) and signalling is triggered. CD3 γ, δ and ε chains possess one and 
CD3 ζ three ITAM motifs, summing their total number to ten per one TCR complex. ITAM 
motif is a specific aminoacid sequence containing two tyrosine residues susceptible to 
phosphorylation. Within seconds after TCR engagement, Lck tyrosine kinase phosphorylates 
the ITAM motifs, initiating one of the first experimentally detectable biochemical changes 
after T-cell activation. Phosphorylated tyrosine of ITAMs recruit ZAP-70, a SYK family 
tyrosine kinase, via its two SH2 domains (Wange et al., 1993). ZAP-70 is then further 
activated by Lck phosphorylation and proceeds to phosphorylate the adaptor protein LAT, 





7.1.2. Downstream signalling 
 
LAT is a transmembrane adaptor protein without any intrinsic catalytic activity. It contains 
the juxtamembrane CxxC motif for palmitoylation which targets the protein to the 
membrane microdomains, the event necessary for its proper function (Zhang et al., 1998). It 
has a number of tyrosine residues, which serve as SH2 domain docking sites upon 
phosphorylation by ZAP-70 (Lin & Weiss, 2001). The association with these SH2 domain-
containing proteins leads to the formation of a large multiprotein complex which serves as 
platform for downstream signalling.  
The signalling complex built around LAT branches into several distinct pathways that are, 
however, tightly interconnected and interdependent. They ultimately lead to the activation 
of transcription factors which converge on numerous promoter sequences to initiate the 
expression of their genes, such as the expression of IL-2 and other cytokines (Fig. 1.1c). 
When LAT is phosphorylated, it is bound by adaptor protein GADS, which in turn binds 
another adaptor protein SLP-76. SLP-76 serves as a docking platform for guanosinnucleotide 
exchange factor (GEF) Vav1, adaptor protein Nck, Tec family kinase Itk and PLCγ1, which also 
binds LAT directly. Itk is then phosphorylated and activated by Lck and in turn 
phosphorylates and thus activates PLCγ1. PLCγ1 then lyses phosphatidylinositol-4,5-
bisphosphate (PIP2) to inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG). 
Consequently, IP3 stimulates opening of Ca2+ channels on the endoplasmatic reticulum, 
which in turn leads to the opening of the Ca2+ channels on the cytoplasmatic membrane, 
providing a sustained influx of Ca2+. Increased calcium level activates calcineurin, which 
dephosphorylates transcription factor NFAT. NFAT is therefore translocated into the nucleus, 
where it alters gene expression in cooperation with other transcription factors. (Brownlie & 
Zamoyska, 2013) 
Meanwhile, DAG in the membrane produced by PLCγ1 is recognized and bound by 
protein kinase Cθ (PKCθ). This enzyme then phosphorylates one subunit of IKK, causing it to 
phosphorylate inhibitor on NFκB (IκB), which serves as a signal for its polyubiquitinylation 
and subsequent degradation of IκB. Once free of the inhibitor, nuclear localization signal of 
NFκB is exposed, NFκB is translocated to the nucleus and triggers the transcription of genes 
relevant for the accomplishment of T cell activation process. (Vallabhapurapu & Karin, 2009) 
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DAG is also bound by another protein important for signalling, Ras guanylnucleotide-
releasing protein (RasGRP). RasGRP is one of two GEFs for small GTPase Ras, the other being 
son of sevenless (Sos). Sos is bound to LAT indirectly by adaptor protein GRB2. Together, 
RasGRP and Sos activate Ras by causing exchange of GDP for GTP (Roose et al., 2007). Ras 
then initiates MAP kinase cascade by activation of Raf1 kinase, which then phosphorylates 
MEK kinase, which in turn phosphorylates Erk, the effector MAP kinase. This leads to the 
engagement of transcription factor AP-1. (Smith-Garvin et al., 2009) 
Figure 1.1 T-cell signalling. T-cell signalling pathway could be divided into three closely 
connected regulation and triggering modules. (a) Lck is negatively regulated via phosphorylation 
by Csk, which is recruited to the membrane by adaptor protein Cbp/PAG. (b) Once TCR is 
stimulated, CD45 phosphatase dephosphorylates the inhibitory tyrosine on Lck. Fully active Lck 
then  phosphorylates ITAMs on the CD3 and activates ZAP-70. ZAP-70 consequently 
phosphorylates adaptor protein LAT (c), which interacts with a number of other proteins. This 
leads to forming of a signalling complex that activates actin polymerisation and multiple 




LAT also stands at the beginning of actin remodelling. Aforementioned adaptor protein 
Nck associated with SLP-76 binds Wiskott-Aldrich syndrome protein (WASP). Vav1 then 
activates Rho family GTPases CDC42 and Rac1, which stimulate WASP and WAVE2 proteins 
responsible for actin remodelling. (Billadeau et al., 2007) 
 
7.1.3. Costimulatory signal 
 
TCR/MHC complex formation alone is insufficient for T-cell activation. On the contrary, it 
leads to anergy, rendering T-cells unresponsive to physiological stimuli (Gimmi et al., 1993). 
T-cell needs a second, so call costimulatory signal to promote T-cell survival and activation. 
This costimulatory signal is provided by molecules of B7 family, CD80 and CD86, which are 
upregulated on activated APCs (Inaba et al., 1994). The absence of B7 molecules contributes 
to peripheral tolerance by inactivating T-cells recognizing antigens on non-activated APCs 
lacking costimulatory molecules. After the recognition of danger signal derived from 
microbes by pattern recognition receptors (e.g. TLRs), APCs upregulate the surface 
expression of costimulatory molecules, whose the presence is the prerequisite for activation 
of T-cells. The costimulatory signal is delivered into the T-cell by CD28, the receptor for CD80 
and CD86. There are also other receptor-ligand pairs that contribute to stimulation or 
inhibition, such as ICOS-ICOSL, PD1-PD-L1, CD40-CD40L (Peggs & Allison, 2005). 
Mechanistically, upon engagement, CD28 binds phosphatidylinositol-4,5-bisphosphate 3-
kinase (PI3K), protein capable of phosphorylation of phosphatidylinositol on the position 3, 
creating phosphatidylinositol-3,4,5-triphosphate (PIP3) (Harada et al., 2001). This 
phospholipid can be recognized and bound by pleckstrin homology (PH) domain. This 
domain is present in Akt protein, as well as its activatory kinase PDK1. After activation, Akt 
phosphorylates number of proteins which support the cell survival and the generation of 
antiapoptotic signals, including attenuation of NFκB, NFAT and Bcl-XL pathways (Smith-
Garvin et al., 2009). CD28 competes for CD80 and CD86 binding with a negative regulator of 
T-cells, CTLA4. This molecule does not provide the costimulatory signal. In contrast, it 
recruits protein tyrosine phosphatases which actively abolish T-cell signalling (Smith-Garvin 





7.1.4. Role of cytoskeleton 
 
During T-cell activation, the cell becomes polarized and MTOC is translocated underneath 
the contact site, the IS. These dynamic processes are fully dependent on the engagement of 
cytoskeleton which is therefore necessary structural component for proper T-cell activation. 
The IS is a specialized area on the membrane on the contact site between T-cell and APC. 
It is formed after TCR stimulation by peptide-MHC and enables sustained activation 
necessary for full T-cell activation (Grakoui et al., 1999). It aggregates proteins of the 
signalling cascades to enhance signal transduction, and also serves as an environment from 
which the negative regulators are sequestered. 
The IS has a structure of three concentric circles. The inner one is called central 
supramolecular activation cluster (cSMAC), middle one is peripheral SMAC (pSMAC) and the 
outmost one is distal SMAC (dSMAC). cSMAC is the heart of the activation, containing TCR 
complex, CD4 or CD8, Lck, PKCθ and CD28. pSMAC harbours integrins (most importantly LFA-
1) and is therefore responsible for maintaining the physical connection with APC. dSMAC 
contains phosphatases such as CD45, that are therefore spatially incapable of counteracting 
the tyrosine phosphorylation-propelled signalling in cSMAC. (Huppa & Davis, 2003) 
The cytoskeleton plays a very important role in the establishment of IS as it is involved in 
the signalling leading to the formation of IS and T-cell polarisation. Crucial for the 
development of the IS are actin microfilaments since without the actin the synapse is not 
formed. After TCR engagement, there is an increase in actin polymerisation which results in 
the formation of lamellipodium that increases contact area between APC and T-cell (Fig. 
1.2). The polymerisation is dependent on Vav1, which activates CDC42 and Rac1, which in 
turn activate WASP and WAVE2 respectively (Billadeau et al., 2007). Both of these proteins 
associate with Arp2/3 complexes and are able to initiate actin polymerisation. Both WASP 
and WAVE2 are indispensable for normal signalling, but appear to play different roles, as 
suggested by their distinct spatiotemporal localizations. WAVE2 appears to be largely 
responsible for the actin polymerization (Nolz et al., 2006), while WASP might be involved in 
endo- and exocytosis (Zhang et al., 1999) and stabilization of the IS. During this process, 
actin also works as a scaffold, as a number of actin-related proteins are engaged in the 
regulation of activation. 
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In the fully formed synapse, actin is restricted to the outer zones of the IS and is virtually 
excluded from the cSMAC, although some residual mircrofilaments has been observed. 
Other cytoskeletal network is placed in the centre of the IS, as the entire microtubule-
organising centre (MTOC) moves and associates with the cSMAC through an Lck-dependent 
mechanism (Tsun et al., 2011) and simultaneously brings Golgi apparatus to the vicinity of 
the IS. This facilitates secretion of cytokines and other protein through the IS directly 
towards the APC. Furthermore, during the formation of the cSMAC, TCR microclusters are 
formed on the periphery of the IS and are moved to its centre, first by actin-mediated 
mechanism (Kaizuka et al., 2007), and then by mechanism depending on microtubules 
(Hashimoto-Tane et al., 2011). 
Figure 1.2 Immunological synapse formation. After TCR recognition of peptide-MHC, T-cell is 
polarised. On the contact site with APC, lamellipodium driven by F-actin extends the area of 
contact, and immunological synapse is formed. In the cSMAC are aggregated signalling molecules 
including TCR, CD4/8, Lck, ZAP-70, LAT and SLP-76. pSMAC harbours integrins, ensuring stable 
association with the APC. On the opposite end of the T-cell is formed distal pole complex, where are 
sequestered some of the proteins involved in the negative regulation of the signalling. Taken from 
(Billadeau et al., 2007) 
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Important role in the formation of IS belongs to ERM proteins erzin and moesin. These 
proteins mediate interaction between actin cytoskeleton and cytoplasmic domains of 
transmembrane proteins. After TCR engagement, they are inactivated and the resulting 
detachment of the cortical actin network decreases the rigidity of the plasma membrane, 
enabling more efficient APC recognition (Faure et al., 2004). ERM proteins are then 
translocated into a distal pole complex (DPC) (Fig. 1.2). DPC is a membrane structure on the 
opposite end of the cell than the IS and serves as a depository for proteins such as CD43, 
PSGL-1 and EBP50, which interacts with Cbp/PAG (Brdickova et al., 2001), a negative 
regulator of Lck (Brdicka et al., 2000). Moesin is consistently found in DPC, while erzin has 
been reported in the IS. Possible explanation for this is the regulation of translocation of 
other proteins. 
 
7.2. T-cell activation models 
 
Despite the fact that the T-cell activation has been studied for several decades, the nature 
of its initial steps remains elusive. Many models have been suggested as to how is the signal 
from pMHC-TCR interaction transferred into the T-cell and to the downstream signalling (van 
der Merwe & Dushek, 2011). These models can roughly be divided into four groups, and are 
not necessarily mutually exclusive (Fig. 1.3). 
 
7.2.1. Multimerisation of TCR 
 
One problem with T-cell activation is low density of agonist pMHC on APC. Some theories 
suggest that the key to this problem is the multimerisation of surface molecules and their 
consequent activation. Besides, it is well established that it is possible to stimulate T-cells by 
artificial multimerisation by antibodies. In the most basic theory, it is heterodimerization of 
TCR with coreceptor CD4 or CD8 (Delon et al., 1998), as they are associated with Lck (Rudd 
et al., 1988; Veillette et al., 1988). However, this cannot be the sole mechanism, as it is 
possible to elicit T-cell response even without the coreceptors (Schilham et al., 1993). More 
complex theories has been therefore proposed, such as pseudodimer theory (Irvine et al., 
2002), which proposes that one pMHC is recognised by two complexes of TCR-coreceptor, 
one using TCR, the other coreceptor, and the latter amplifies the signal by interaction with 
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distinct self-peptide-MHC. This model has been 
discounted by the fact that MHC has a limited 
propensity to form dimers, even though, the 
formation of such complexes has been reported 
(Choudhuri & van der Merwe, 2007). Collectivelly, 
the receptor multimerization is not considered as 
the major driving mechanism of T cell proximal 
signaling, although it certainly propagates and 
enhances the signalling. 
 
7.2.2. Change of conformation 
 
This group of theories revolves around a very 
simple but strong premise that stimulated TCRs 
change their conformation or position with 
regards to neighbouring proteins. There is 
evidence suggesting that conformational change 
alone can induce at least some of the downstream 
signalling pathways (Gil et al., 2002). Nevertheless, 
it seems unlikely that all the possible variety of the 
antigen recognition sites that are created largely 
by a random recombination would be able, upon 
the engagement, to undergo the same 
conformational in the cytoplasmic segments of 
TCR/CD3 chains. More complex theories 
Figure 1.3 T-cell activation models. There are several theories trying to explain the mechanism 
of T-cell activation. Some of them see the key mechanism in clustering of TCR with CD4/8 (a) or 
distinct TCR complex (b). Next group expects that the activation is based on a conformational 
change between complexes (c), molecules within a single complex (d) or change in the relative 
position to the membrane by mechanical forces (e). In the kinetic segregation model, the activation 
is achieved by removing tyrosine phosphatases from signalling molecules due to their bulky 
extracellular domains (f), while lipid raft theory considers as crucial the translocation of the TCR 
complex to the lipid raft, where the rest of signalling machinery is located (g). Taken from 
(Choudhuri & van der Merwe, 2007) 
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circumvents this objection by moving from intramolecular change to intermolecular, 
suggesting positional changes of one TCR with respect to another (Ding et al., 1999) or 
changes in mutual position of CD3 polypeptides to TCR complex or TCR complex itself within 
their multimers (Choudhuri & van der Merwe, 2007). This group also includes theories 
according to which the signal is transduced by a mechanical force exhorted on TCR upon 
engagement (Ma et al., 2008). Such mechanical forces have indeed been determined on the 
T-cell-APC (Li et al., 2010). 
 
7.2.3. Kinetic segregation 
 
The last model of T-cell activation is based on the mechanism of selective inclusion and 
exclusion of various proteins from the site of the forming IS based on the size of their 
extracellular domains (Davis & vanderMerwe, 1996). Specifically, many proteins required for 
activation of T-cells possess a relatively small extracellular domain; among those proteins are 
TCR, CD4, CD8 and CD28. The same applies to their binding partners on APCs, MHC and 
CD80/86. On the other hand, extracellular domains of phosphatases such as CD45 and 
CD148 are much larger (Fig. 1.4). These phosphatases are very potent and are capable of 
counteracting the tyrosine phosphorylation on ITAMs of CD3 and thus prevent the 
downstream signalling (Hui & Vale, 2014).  
During the formation of the IS, a close membrane apposition limits the space for the 
interaction between MHC and TCR. Bulky extracellular domains of the phosphatases simply 
do not fit this confined space. They are therefore pushed out of this area  and consequently 
the balance between tyrosine phosphorylation and dephosphorylation is nudged towards 
the former (Cordoba et al., 2013). 
This model is in agreement with the ‘standby model’ of TCR triggering proposed by Nika 
and colleagues (Nika et al., 2010). Their and other’s findings (Paster et al., 2009) suggested 
that a substantial pool of Lck in naïve T-cells is activated prior to TCR engagement and upon 
T-cell activation remains constant. This is in a sharp contrast with previous dogma which 
dominated the field for previous 20 years that Lck is largely activated de novo after the TCR 
triggering. However, the persistence of the preactivated pool of Lck requires a mechanism 
preventing spontaneous triggering of T-cell activation. The authors suggested that the 
presence of CD45 phosphatase activity is sufficient to counteract SFK kinase activity through 
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highly effective dephosphorylation of CD3ζ chains, the proposition which finds its support in 
recently published experiments (Hui & Vale, 2014; Nika et al., 2010). 
 
7.2.4. Membrane microdomains 
 
Another group of theories is based on the observed importance of membrane 
microdomains, or lipid rafts (LR), for TCR signalling (Horejsi, 2005). These models suggest 
that after the stimulation of the TCR, the entire TCR complex is translocated into the LR. LR 
represents a distinct membrane subcompartment, which concentrate molecules important 
for signal transduction, such as LAT. The translocation brings the TCR complex capable of 
initiation of the signalling to a specific environment conducive for sustained signal 
transduction into the interior of the cell.  
An important role in this mechanism has been attributed to the translocation of Lck into 
LR and its subsequent interaction with Fyn, another member of SFKs  (Filipp & Julius, 2004). 
In primary naive CD4+ T-cells Fyn is LR-resident protein and up to 98% is reproducibly 
detected in this membrane subcompartment. On the other hand, 75-95% of Lck is located 
Figure 1.4 Sizes of extracellular domains of selected signalling molecules. Kinetic segregation 
theory expects exclusion of tyrosine phosphatases CD45 and CD148 from the immunological 
synapse because of their large extracellular domains that would not fit the space between 
membranes on the contact site between TCR and MHC, both of which have small extracellular 
domains. Integrin LFA-1, which has a medium-sized extracellular domain, can be found in the 
peripheral ring of the immunological synapse. Taken from (van der Merwe et al., 2000) 
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outside the lipid rafts prior to the T-cell activation. After TCR engagement by coaggregation 
of CD4 and TCR, Lck is activated and within seconds rapidly translocates alongside TCR and 
CD4 to the lipid rafts, where it activates Fyn (Filipp et al., 2003). The translocation 
mechanism, however, remains obscure. It appears to be dependent on the kinase activity of 
Lck, since kinase inactive mutants fail interact with Fyn and activate it (Filipp et al., 2008). It 
has also been suggested that the C-terminus of Lck may play role in this translocation. It has 
been shown that its sequential truncations lead to the loss of translocation capability and 
diminishment of kinase activity of Lck and subsequently decreased IL-2 production (Filipp et 
al., 2008). We hypothesized that the C-terminus of Lck may be involved in a previously 
undescribed protein-protein interaction which allows its translocation to LR via linking to the 
elements of cytoskeletal network. Using the comparative 2D electrophoresis coupled with 
mass spectrometry analysis several candidate proteins were identified (Filipp, unpublished 
data). Using this screen, one of the most suitable Lck interaction candidate partner has been 
identified as adaptor protein RACK1 – Receptor of activated C kinase. The interaction of Lck 





Lck is a prototypical member of SFKs, a group of essential nonreceptor tyrosine kinases 
involved in signal transduction. Three kinases of this family, Src, Yes and Fyn are ubiquitously 
expressed, while other members of the family (Fgr, Lck, Hck, Blk, Lyn and Frk) show more cell 
type specific expression pattern (Thomas & Brugge, 1997). Specifically, Lck expression is 
confined to leukocytes (Perlmutter et al., 1988), with highest expression levels in T-cells and 
NK-cells and low expression in B-cells and dendritic cells. 
 
7.3.1.  Structure of Lck 
 
The overall structure of Lck is the same as other SFKs. It consists of four domains, called a 
unique, SH3 (Src homology 3), SH2 and kinase, or SH1, domain. In addition, three 
functionally distinct segments can be also distinguished: (i) the N-terminal sequence 
responsible for the attachment of Lck to the membrane (see below), (ii) a proline-rich region 
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placed between SH2 and SH1 domain, and (iii) an unstructured C-terminal tail, which 
contains tyrosine residue Y505 that is crucial for the negative regulation of the kinase. 
A relatively short N-terminal sequence of 10 aminoacids of Lck contains three potential 
sites for acylation, specifically myristoylation on glycine in position 2, and palmitoylation on 
cysteins in position 3 and 5 (Abraham & Veillette, 1990; Koegl et al., 1994). These lipid 
modifications mediate Lck targeting into LR, which appears to be important for Lck function.  
The following unique domain is the only sequence in which all SFKs differ significantly and 
is thus often used for the generation of a kinase specific antibody. Furthermore, this domain 
bears a dicystein motif, which via zinc ion coordinates the interaction between Lck and CD4 
or CD8 coreceptor (Kim et al., 2003). If this interaction is interrupted, the T-cell activation is 
prevented. Moreover, Lck binding to CD4 prevents the internalization and degradation of 
the latter by masking its dileucine internalisation motif. 
SH3 domain is a protein domain fold widely used in various proteins. It is able to interact 
with proline-rich sequences in polyproline helix type II conformation. Such a helix displays a 
shape of a triangle on an intersection with proline residues on one side. The proline residues 
intercalate between the aromatic residues of the SH3 domain and form a stable complex 
(Feng et al., 1994). 
Similar to SH3 domain, SH2 domain is also very common in signalling proteins. It is 
capable of inducible binding to a phosphorylated tyrosine residue. It contains two pockets 
responsible for the recognition; one binds the phosphotyrosine, the other one binds a 
hydrophobic residue, preferably isoleucine (Waksman et al., 1993). Between these two 
aminoacids are two other residues that are less important for binding, but, nevertheless, 
play a role in its binding specificity. The optimal consensus binding sequence of SH2 domain 
of Lck is pYEEI (Zhou et al., 1993). 
The only domain in Lck that exhibits a catalytic function is the kinase domain. It is 
analogous to other kinase domains and contains an N-lobe and a C-lobe with catalytic cleft in 
between. An important part of the C-lobe is an activation loop, whose tyrosine 
phosphorylation in position Y394 increases the activity of Lck by displacing it from a position 
preventing the kinase domain to acquire the optimal conformation for the catalysis (Xu et 




The C-terminus of Lck is an 11 aminoacids long unstructured tail. Despite its shortness, it 
is extremely important as it carries a negative regulatory tyrosine crucial for keeping Lck in 
inactivated or closed conformation. Other mechanism how the C-terminal tail sequence 
imposed its effect on the function of Lck has been proposed (Filipp et al., 2008). This 
additional mode of action is described below and is the subject of investigation presented in 
this thesis. 
 
7.3.2.  Regulation of Lck 
 
Activity of Lck is regulated by tyrosine phosphorylation. This phosphorylation is regulated 
by several additional proteins and their action results in important changes in the structure 
of Lck. 
 
7.3.2.1. Conformational forms 
 
The regulation of Lck is based on phosphorylation of two regulatory tyrosines, activatory 
Tyr394 and inhibitory Tyr505. The activatory tyrosine 394 is located in the activation loop of 
the kinase domain and its phosphorylation enables more efficient phosphorylation of the 
substrate. In contrast, the regulation by phosphorylation of Tyr505 downregulates the kinase 
activity by causing the formation of intramolecular interactions between pY505 and its own 
SH2 domain (Xu et al., 1999).  
Although the SH2 and SH3 domains are on the opposite site of the kinase domain relative 
to its catalytic cleft, their interaction with pY505 and polyproline helix, respectively, change 
the angle between C- and N-lobes and decreases flexibility of the catalytic cleft, which 
results in decrease of the kinase activity (Cowan-Jacob et al., 2005). 
Three conformational states of Lck have been described with regard to its activity and 
phosphorylation state, termed closed, primed and open (Fig. 1.5). Closed and catalytically 
inactive conformation has phosphorylated Tyr505 bound to SH2 and both SH3 and SH2 
domains are packed against the kinase domain. Primed conformation has neither of the 
regulatory tyrosines phosphorylated and SH3 and SH2 domain are thus unbound. The 
catalytic activity is approximately five times higher than that with the closed conformation 
with  pTyr505 Lck (Hui & Vale, 2014). The phosphorylation on Tyr394 leads to additional two-
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fold increase in Lck activity, making it 
approximately ten times more active than 
Lck with a closed conformation (Hui & 
Vale, 2014).  
In 2010, Nika et al.(Nika et al., 2010) 
described a previously observed but 
ignored phosphorylation state whereby 
Lck carries both Tyr394 and Tyr505 
phosphorylated. Despite the 
phosphorylation of the inhibitory tyrosine, 
this form of Lck is active matching the 
kinase activity of primed Lck (Hui & Vale, 
2014; Nika et al., 2010). The 
conformational status of this form has not 
been addressed, but based on the kinase 
activity, SH3 and SH2 domains are unlikely 
to form intermolecular interactions. 
 
7.3.2.2. Regulation of 
phosphorylation 
 
The activation on Tyr394 is mediated 
by trans-autophospharylation between 
two molecules of Lck (Hui & Vale, 2014). 
Lck has also been showed to cause trans-
autophosphorylation on Tyr505, although 
the main protein performing this 
inhibitory phosphorylation is Csk 
(Bergman et al., 1992). This kinase is considered to be a key negative regulator of Lck and its 
knockout leads to a spontaneous activation of T-cells (Schmedt et al., 1998). However, Csk is 
a cytosolic protein, whereas most of Lck is membrane-bound. For the purpose of 
Figure 1.5 Conformational forms of Lck. Lck 
can be found in four conformational forms, based 
on the phosphorylation status of two regulatory 
tyrosines. Primed conformation carries no 
phosphorylated tyrosine and exhibits a basal level 
of kinase activity. The activity can be minimized 
by phosphorylation on negative regulatory Tyr505, 
which leads to the acquisition of closed 
conformation caused by intramolecular interaction 
of the SH domains. Phosphorylation of the 
activatory Tyr394 on the other hand leads to a full 
activation of Lck by fixing activation loop in a 
position favouring the phosphotransfer reaction. 
Double phosphorylated form has been described as 
mostly derived from an active conformation and its 
activity is comparable with that of primed form of 
Lck. Modified from (Harrison, 2003) 
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translocation to the membrane, Csk binds to a membrane adaptor protein Cbp/PAG, thus 
enhancing the kinetics of Lck phosphorylation (Brdicka et al., 2000). Furthermore, it 
associates with PEP phosphatases, capable of dephosphorylation of pTyr394, which 
strengthen the inhibitory effect of Csk (Cloutier & Veillette, 1996). 
The main regulatory phosphatase of Lck is CD45, a very potent enzyme abundantly 
expressed in T-cells. It is able to dephosphorylate both activatory and inhibitory tyrosines, 
predisposing them for activation or inhibition, depending on the actual needs (Mustelin & 
Altman, 1990). Its overall effect on Lck is considered to be activatory, since the primed 




Receptor for activated C-kinase 1 (RACK1) belongs to an ancient and conserved family of 
WD40 proteins. Members of this family are present in all eukaryotes and even some 
prokaryotes (Li & Roberts, 2001). The family of these proteins contain four to sixteen WD40 
repeats. The most typical and conformationaly favoured number of repeats is seven. These 
proteins acquire a doughnut-shaped conformation of seven-bladed β-propeller (Carrillo et 
al., 2012). Each WD40 repeat consists of four β-sheets, first of which is part of the previous 
structural segment (Fig. 1.6). The loops between the β-sheets form variable surfaces capable 
of interaction with many other proteins. On the β-propeller structure, proteins can bind to 
its top, circumference or the bottom. The most commonly used is the top (Stirnimann et al., 
2010), and commonly used site is the central channel (Russell et al., 1998). This extensive 
binding surface predicates WD40 proteins to work as scaffolding proteins and to regulate 
other proteins by specific interactions. WD40 domain also belongs to the most common 
folds, which indicates its importance (Stirnimann et al., 2010). While WD40 domain itself 
never possesses the catalytic activity, they can be part of a protein whereby such activity is 
executed by other linked domains (Stirnimann et al., 2010). 
 
7.4.1. Roles of RACK1 
 
RACK1 is a 36kDa seven-bladed β-propeller protein with no additional domains (Yatime et 
al., 2011). It is able to interact with many proteins including itself (Yatime et al., 2011). 
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RACK1 deficiency in mice is lethal during gastrulation, although heterozygotes compensate 
the gene dosage and their phenotype is very mild (Volta et al., 2013). Although it has no 
catalytic activity, it is an important protein, as it is part of various protein complexes in 
signalling pathways, it is involved in the regulation of ubiquitinylation (Zhang et al., 2012), 
transcription (Ceci et al., 2003; Kouba et al., 2012) and circadian rhythm (Robles et al., 2010). 
Its propensity for homodimerisation expands its capacity to bind proteins which share the 
same docking site on RACK1 (Thornton et al., 2004). Its importance is underlined by its high 
evolutionary conservation (Neer et al., 1994). Some of the most important roles of RACK1 
are briefly outlined below. 
RACK1 was observed as a member of various signalling pathways, serving as an adaptor 
protein. To this day, almost 160 proteins have been reported to be associated with RACK1 
(thebiogrid.org). This numerous binding capability predisposes RACK1 for mediating protein-
protein interactions. Later another cellular pool of RACK1 was identified, associated with 
ribosomes, where it plays an indispensable role in activation of translation (Shor et al., 
2003).  
RACK1 was first described as a protein binding activated PKCβII and translocating it within 
the cell to a distinct location (Ron et al., 1994). RACK1 is able to associate also with other 
isoforms of PKC. Therefore it can recruit other proteins to the vicinity of PKC or move PKC to 
Figure 1.6 Structure of RACK1. RACK1 has a structure of seven-bladed β-propeller. It consists 
of seven WD40 repeats forming seven structural elements. Each element consists of four β-sheets, 
first of which belongs to a previous WD40 repeat. Loops between the sheets provide diverse 
binding sites and enable the interaction of RACK1 with a plethora of other proteins. Taken from 
(Coyle et al., 2009). 
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their proximity. For example, it has been showed to mediate the crosstalk between PKC with 
MAP kinase pathway by associating with MAP kinase JNK (Lopez-Bergami et al., 2005). 
RACK1 has been detected in the crystal structure of the small 40S subunit of the ribosome 
(Sengupta et al., 2004). Being position on the surface of the ribosome, it can serve as a 
platform for aggregation of signalling molecules. Among others, it has been shown to 
interact with the transcription initiation factor eIF3 which is essential for the  regulation of 
transcription (Kouba et al., 2012). Also, the recruitment of PKCβII to the ribosome by RACK1 
is crucial for the initiation of translation (Ceci et al., 2003). In this scenario, PKC 
phosphorylates eIF6, which consequently dissociates and allows the association of small and 
big subunit of the ribosome, thus initiating translation. On the other hand, RACK1 can also 
promote the repression of gene expression. This is mediated by the mechanism where 
RACK1 can enhance the recruitment of miRNA silencing complex directly to the ribosome 
(Jannot et al., 2011). It has also been shown that RACK1 participates in the nascent peptide-
dependent translation arrest (Kuroha et al., 2010). 
Upon the signal by cAMP, RACK1 can be translocated to the nucleus by 14-3-3ζ protein. 
Once there, it is capable of altering the expression by promoting histone acetylation what 
leads to the production of c-Fos, which in turn changes the expression pattern of numerous 
other proteins (He et al., 2002). 
RACK1 also plays a regulatory role in neurons. GABA receptor is modulated by 
phosphorylation caused by PKC, which is dependent on RACK1 (Brandon et al., 2002). 
Glutamate receptor NMDAR is also regulated by RACK1. It brings Fyn kinase to its proximity 
by homodimerization (Thornton et al., 2004), but Fyn cannot increase activity of the 
receptor by phosphorylation until both Fyn and NMDAR are released from RACK1 upon 
cAMP signalling (Yaka et al., 2002). 
Protein translocation by RACK1 is used also in the regulation of cytoskeleton. RACK1 
interacts with plectin, protein interacting with all three elements of cytoskeleton 
(Osmanagic-Myers & Wiche, 2004). This study defines plectin as a protein sequestering 
RACK1 to the cytoskeleton, and plectin-RACK1-PKC complex is released after stimulation of 
the cell by EGF, leading to the formation of focal adhesions. RACK1 plays an important role in 
formation of focal adhesion. It binds β chains of integrins, Src and FAK kinases and integrates 
signals from integrins with those from growth factor receptors (Cox et al., 2003). Src then 
phosphorylates FAK and hence increasing its activity (Kiely et al., 2009). 
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Src family kinases Src, Fyn and Lck have been shown to bind RACK1 (Chang et al., 1998). 
This interaction has an inhibitory effect on their kinase activity (Chang et al., 1998). Src is 
bound to the phosphotyrosine 246 on the sixth WD40 domain (Chang et al., 2001). Src itself, 
in turn, is capable of phosphorylation of Tyr228 and Tyr246 on RACK1 (Chang et al., 2002). 
Other four tyrosines on RACK1 are phosphorylated by different kinases. 
All these mechanisms, in which RACK1 plays an important role, indicate that this molecule 
is highly versatile and play a pleiotropic function in the translocation mechanisms of other 
proteins during activation events. Thus RACK1 was a well-suited candidate, identified in our 
functional screen, which could orchestrate the translocation of Lck to the lipid rafts during 
early phases of T-cell signalling. This potentially novel role in T cell activation was the main 




8. Material and Methods 
 
Cell lines  
NIH3T3 and SYF fibroblast lines were maintained in Iscove’s Modified Dulbecco’s Medium 
(IMDM) (Gibco); HEK293T, HEK293, AD 293 fibroblast cell lines were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) (Life Technologies); J774.2 macrophage cell line 
and Jurkat T-cell line were maintained in RPMI 1640 (Life Technologies). All media were 
supplemented with 10% of inactivated fetal calf serum (FCS) and 100 Units of penicillin / 
10µg streptomycin antibiotics (Sigma) per 1 ml of media. 
 
Mice 
Double transgenic mice tg D011.10 TCR / tg CARΔ (TgCAR) (Taconic) mouse strain expressing 
human coxsackie/adenovirus receptor lacking a cytosolic domain (Murphy et al., 1990; Wan 
et al., 2000a) six to eight weeks old, were used for experiments. Mice were housed in a 




PCR constructs created using Pfu polymerase (Thermo Scientific) were first cloned into pJET 
using CloneJET PCR Cloning Kit (Thermo Scientific) according to manufacturer’s instructions. 
Then they were excised by restriction endonucleases and ligated into definitive plasmid. 
Constructs were verified by sequencing. 
 
Plasmids 
Lck and RACK1 constructs were cloned into MIGR1 (Pear et al., 1998) , plasmid with EGFP 
under control of IRES. Constructs for in-vitro translation were cloned into pET-42 (a gift from 
laboratory of Dr. Vladimír Kořínek; contains GST tag) or pET-15 (a gift from laboratory of Dr. 
Jan Černý) after it was provided with 3xFLAG tag derived from Sigma plasmids. HA-RACK for 
preparation of adenovirus was cloned into pSH-UP-UP (gift from laboratory of Dr. James 
DeGregory, University of Colorado) (Fig. 3.4a), plasmid with two ubiquitin promotors, one 





ΔC7, ΔC9 and new ΔYQPQP mutants were created by GeneTailor site-directed mutagenesis 
system (Invitrogen) according to the manufacturer’s instructions.  
 
Bacteria transformation 
50 μl of TOPO10 E. coli were thawed on ice, plasmid or ligation mixture was added, and kept 
20 minutes on ice. Cells were then warmed to 42 °C for 90 seconds and cooled on ice for 1 
minute. Then was added 200 μl of pre-warmed SOC medium (Invitrogen) and cells were 
shaking for 30 minutes at 37 °C. Cells were then seeded on plates with an antibiotic 
according to the plasmid (kanamycin or ampicillin). 
 
Plasmid isolation 
Plasmids from 3 ml (QIAprep Spin Miniprep Kit, Qiagen) or 100 ml (QIAGEN Plasmid Midi Kit, 
Qiagen) of overnight bacterial culture were harvested according to the manufacturer’s 
instructions. Plasmid concentration was determined spectrophotometrically using Nanodrop 
ND-1000 (Thermo Scientific). 
 
Transient transfection of the cells 
Overnight, approx. 70% confluent culture of the cells was transfected using Lipofectamine 
LTX or Lipofectamine 2000 (Life Technologies) according to the manufacturer’s instructions. 
 
Creation of stable cell lines (retroviral cell infection) 
HEK 293T cells were transfected with equal amounts of GAG-POL, ENV and desired plasmid. 
Next day, medium of SYF cells was replaced by retrovirus-containing medium from HEK 293T 
cells; their medium was replenished. Same procedure was performed next day. After 
sufficient propagation of SYF cells, GFP-positive SYF cells were sorted. 
 
Flow cytometry and cell sorting 
FACS analysis was performed on LSRII or FACSCalibur cytometers (BD Biosciences). Data 
were analysed by FlowJo software. Cell sorting was performed by Zdeněk Cimburek on Influx 






Anti-Lck   Gift from laboratory of prof. Václav Hořejší 
Anti-pY394 Lck  Santa Cruz 
Anti-pY505 Lck  Invitrogen 
Anti-RACK1   Santa Cruz 
Anti-FLAG   Sigma 
Anti-GST   Gift from laboratory of prof. Václav Hořejší 
Anti-HA   Sigma 
Anti-GFP   Abnova 
Anti-Myc   Gift from laboratory of prof. Václav Hořejší 
Anti-GADS   Santa Cruz 
Anti-pY (4G10)  Gift from laboratory of prof. Václav Hořejší 
Anti-GAPDH   Sigma 
Anti-TCRβ (biotinylated) eBioscience 
Anti-CD4 (biotinylated) eBioscience 
Anti-CD69 – PE-Cy7  eBioscience 
Anti-CD62L – PE  eBioscience 
Anti-CD25 – PE  eBioscience 
 
Secondary antibodies 
Goat-anti-Mouse HRP   BioRad 
Goat-anti-Rabbit HRP    BioRad 
IRDye 680 anti- Mouse   LI-COR 
IRDye 800 ant- Rabbit   LI-COR 
Goat-anti-Mouse light chain specific  HRP Jackson ImmunoResearch Laboratories 
Mouse-anti-Rabbit light chain specific HRP Jackson ImmunoResearch Laboratories 
 
SDS PAGE and western blotting 
Samples were boiled for 10 minutes in 2x Laemmli sample buffer and then resolved on 8%, 
10% or 12% polyacrylamide gels. Proteins were transferred onto PVDF membrane (Millipore) 
and blocked for 1 hour in 5% non-fat milk at RT. Blots were then incubated for 1 hour with 
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primary antibody diluted in blocking buffer, washed and incubated for 1 hour with 
secondary antibody conjugated to horseradish peroxidase (HRP), developed by incubation 
with ECL substrate (Thermo Scientific) and visualised by X-ray films. Blots for 
phosphotyrosine staining or analysis by fluorescence scanner were blocked for 1 hour in 3% 
gelatine in TBS-T at 37°C. Blots were then incubated for 1 hour with primary antibodies 
diluted in blocking buffer, washed and incubated for 1 hour with secondary antibodies 
conjugated fluorescent dye (IRDye) and scanned on Odyssey CLx Infrared Imaging System 
(LI-COR). Phosphotyrosine staining could be determined also by ECL substrate. Densitometry 
quantification was performed by AIDA image analyser software from the raw image data.  
 
T-cell isolation and activation 
The method was described in (Ballek et al., 2012). Briefly, CD4+ T-cells were isolated from 
lymph nodes and purified by MACS CD4+ T-cell isolation kit (AutoMACS, Miltenyi Biotec) to 
~95% purity. T/cells were precoated in biotinylated antibodies anti-TCR (1 µg/ml) and anti-
CD4 (0,3 µg/ml), washed and activated by antibody-crosslinking by streptavidin (final 
concentration of 50 µg/ml in 20 μl). Activation was ended by addition of Laemmli sample  
 
Adenovirus production and transduction of T-cells 
HA-RACK was cloned into pSH-UP-UP plasmid. It was used for production of adenoviruses by 
AdEasy™ Adenoviral Vector System (Agilent Technologies) according to the manufacturer’s 
instructions. Virus was created and amplified in AD-293 cells. Isolation of virus was 
performed when cytopathic effect of the virus was present (Fig. 2.1). Virus titer was 
determined by AdEasy™ Viral Titer Kit (Agilent Technologies) and MOI was calculated. 
Transduction of naïve CD4+ T-cells isolated from CAR mice was performed as described 
elsewhere (Zha et al., 2008). Briefly, T-cells were resuspended in DMEM with 2%. Viral 
particles are added at desired MOI and cells are incubated for 1 hour at 37°C. Cell with virus 
is then cultured at 37°C in complete RPMI 1640 medium supplemented with 2ng/ml IL-7 







BMDC preparation and T-cell activation 
Bone marrow was isolated from femurs and tibias of mice, erythrocytes were lysed by ACK 
buffer, remaining cells were washed and cultured in RPMI with GM-CSF for 7 days. Cultured 
cells were considered to be bone marrow-derived dendritic cells (BMDC). 
BMDC were pulsed by OVA323-339 peptide for 2 hours and mixed with CD4
+ T-cells at 1:4 ratio 
for T-cell activation. CD69 and CD25 production was analysed by FACS. 
 
Proliferation assay 
CD4+ T-cells were stained by eFluo670 proliferation dye (eBioscience) for 10 min, washed 
and mixed with BMDC pulsed by OVA323-339 peptide for 2 hours at 4:1 ratio. After 72 hours, 
cells were stained against CD4 and analysed by FACS. 
 
In-vitro translation 
TnT® T7 Quick Coupled Transcription/Translation System (Promega) was used. To 40 μl of 
mastermix was added 1μg of plasmid, 1 μl of methionine and water to 50 μl. The reaction 
was kept on 30°C for 90 minutes. 2 μl were used as control of successful transcription and 
11,5 μl was used for immunoprecipitation experiments. 
 
Immunoprecipitation 
Cells were lysed in TNE buffer containing 1 % on NP-40 and protease and phosphatase 
inhibitor cocktails (Roche). Lysates were incubated on ice for 30 min; nuclei were then spun 
Figure 2.1 Cythopatic effect of adenovirus. Adenovirus amplification induces cytopathic efect. 
Compared to uninfected cells (left), infected cells round up and lose adhesion. 
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down (800 RPM, 2 min, 4°C) and discarded. In vitro translation reactions were diluted in TNE 
buffer containing 1 % on NP-40 or RIPA buffer. Lysates were loaded on agarose anti-HA 
conjugated beads and incubated overnight 4°C. Alternatively, lysates were pre-cleared by 
unprecoated magnetic beads, and then loaded on magnetic beads precoated by antibody 
and incubated overnight at 4°C. Beads were washed 6 times by lysis buffer and boiled in 2x 









9.1. The role of the C-terminus of Lck in the complex formation with RACK1 
 
RACK1 has been identified as the candidate Lck interacting partner based on its tyrosine 
phosphorylation which was dependent on the presence of the intact C-terminal tale of Lck 
(Filipp et al., 2008). Based on our previous and already published results we predicted that 
the progressive truncations of the tail will have no or only a limited impact on the kinase 
activity of Lck, but will negatively affect its capacity to interact with RACK1 as well as to 
phosphorylate its multiple intracellular targets (Filipp et al., 2008). In order to precisely map 
the sequence and the requirement for this Lck tail segment in this interaction, we created 
stable cell lines expressing various mutated forms of Lck. The cell lines were derived from 
SYF cells, mouse fibroblasts that lack the expression of the triad of ubiquitously expressed 
SFKs, Src, Yes and Fyn (Klinghoffer et al., 1999). Therefore the only expressed SFK in these 
cells was the wild type and various mutant form of Lck introduced into these cells 
retrovirally. 
 
9.1.1. Preparation of mutant cell lines 
 
Mutated Lck forms were cloned into Migr1, a plasmid with EGFP under control of IRES 
downstream of the cloned protein, which enables retrovirus encapsulation. Migr1 empty 
(control), WT (wild type Lck), W97A (SH3 domain inactive), R154K (SH2 domain inactive), 
K273A, Y394F (both kinase domain inactive), Y505F (constitutionally active), ΔQP, ΔQPQP, 
ΔYQPQP and ΔC11 constructs (Fig. 3.1a, b) were prepared as described previously (Filipp et 
al., 2008). Migr1 with ΔC7 and ΔC9 Lck mutants were prepared by the site-directed 
mutagenesis. All the truncation mutants were created on Y505F Lck template. Retroviral 
particles containing the constructs were created and used for SYF cells infection. SYF cells 
infected with retroviral particles carrying the Lck constructs were sorted out based on an 
equal expression of EGFP. During the sequencing analysis, we discovered a possible 
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mutation in a previously prepared plasmid with ΔYQPQP mutation and thus we generated its 
new version from ΔQPQP template. 
 
 
Figure 3.1 Influence of C-terminus on activity of Lck and its interaction with RACK1. 
Functional mutants of Lck were prepared, disabling SH3 (W97A), SH2 (R154K), kinase domain 
(K273A, Y394F) and negative regulatory segment (Y505F) (a), and cloned into Migr1 plasmid. A 
series of mutants containing progressive C-terminal truncations was prepared on the background 
of constitutively active (Y505F) Lck (b). It was previously shown that SH2, SH3 and the C-
terminus of Lck are important for binding of RACK1 in NIH3T3 cells  (c) (Ballek, 2009). We 
created cell lines with stable expression of our constructs in SYF cells which, unlike NIH3T3, 
lack the expression SFKs. These cells were then analysed for their global tyrosine 
phosphorylation (d). They were also used for experiments determining the influence of the 




9.1.2. Tyrosine phosphorylation status 
 
First, we assess the kinase activity of the wild type and mutated forms of Lck. The total 
lysates from infected SYF cells were stained by phosphotyrosine-specific antibody (4G10) 
(Fig. 3.1d). The observed tyrosine phosphorylation pattern can be attributed only to Lck 
since the background signals in mock cells infected with the control empty plasmid as well as 
those with the kinase inactive Lck, are negligible. As expected, the WT and kinase dead 
(K273A, Y394F) mutants showed limited or no phosphorylation. Somewhat unexpectedly, 
and as illustrated in Fig. 3.1d, phosho-pattern of some Lck mutant constructs differed from 
those previously published (Filipp et al., 2008). Specifically, SH2 domain mutant (R154K) no 
longer possessed the expected kinase activity. In contrast, and in the context of the main 
purpose of this experiment, we did not see the expected pattern of kinase activity in the tail 
truncation mutants. While published data showed virtually no Lck activity of ΔYQPQP mutant 
towards its intracellular targets, the kinase activity of all truncation mutants in our 
experiments was comparable, and in case of ΔYQPQP even slightly elevated in comparison to 
that expressing the constitutively active Y505F. There was some decrease in the activity of 
ΔQP, but no clear and reproducible pattern could be identified. 
 
9.1.3. RACK1-Lck interaction 
 
Next, we tested whether the C-terminal sequential truncations of Lck impact its 
interaction with RACK1.  It was previously shown that in NIH3T3 cell lines, SH3, SH2 and the 
C-terminal tail of Lck are involved in binding to RACK1 (Fig. 3.1c) (Ballek, 2009). We therefore 
performed the immunoprecipitation of RACK1 from freshly prepared SYF cells infected with 
Lck mutant constructs and compare the amount of Lck present in the complexes (Fig. 3.1e). 
Results confirmed that both SH3 and SH2 domains are involved in the interaction with 
RACK1. Specifically, as W97A and R154K mutants exhibited decreased binding, but neither 
mutant abolished this interaction completely. Y394F Lck mutant with removed activatory 
tyrosine 394 also caused severe diminishment of this interaction. The only apparent C-
terminal truncation which exhibited influence over the Lck-RACK1 , interaction was ΔC9 
mutant whose binding to RACK1 was decreased to the level comparable to those of SH2 and 




Thus, the immunoprecipitation of RACK1 in the SYF cell lines demonstrated that Lck 
interacts with RACK1. It further confirmed that this interaction is dependent on functional 
SH2, SH3 and to certain extend also the C-terminal tail of Lck. However, the limitation of this 
type of analysis is that it could not give us further insight into the specific mechanism of 
these interactions, i.e. whether the interaction between Lck and RACK1 is direct or mediated 
Figure 3.2 Interaction of Lck and RACK1 in cell cultures. Plasmids containing HA-RACK1, c-
myc-EGFP as negative control, c-myc-EGFP-SH3, c-myc-EGFP-SH2 and c-myc-EGFP-SH3SH2 
were created. HA-RACK1 was transfected to HEK293T cells alone or together with SH domains 
containing constructs (a).  These cells were used for the immunoprecipitation of HA-RACK1 (IP: 
HA-RACK1) for the determination of its interaction with lck structural components (b). Two 
different times of exposure of the same membrane are displayed. Because the negative control 
showed a high background non-specific interaction (red arrow), an unnecessary sequence of 
multiple cloning site was removed, resulting in much reduced background signal (c). The IP:HA-
RACK1 experiment was repeated, using shortened control (d); the interaction of control was still 
detectable, but lower than interaction of SH2 and SH3SH2 domains. SH2 domain was further 
analyzed for the specificity of binding, showing interaction with anti-HA beads even without 




through some intermediary products. We therefore decided to assess the capacity of SH2 
and SH3 domains to associate directly with RACK1.  
 
9.1.4. RACK1-SH2 and -SH3 Lck pull down assays 
 
To address the Lck binding abilities to RACK1, several recombinant constructs from Lck 
and RACK1 were prepared. The full size molecule of RACK1 and separate sequence of SH2, 
SH3 as well as combined SH2-SH3 domains of Lck were tagged with HA oligopeptide and 
Myc-EGFP protein, respectively. HA-RACK1, Myc-EGFP-SH2, Myc-EGFP-SH3, Myc-EGFP-
SH3SH2 and control Myc-EGFP constructs were prepared by Adela Brouckova, the former 
postdoc in our lab. After confirming that the proteins are well expressed (Fig. 3.2a), the 
constructs from Lck were cotransfected together with HA-RACK1 to HEK293T cells. 
Subsequently, pull-down assay was performed, using anti-HA antibody. We observed the 
interaction of HA-RACK1 with SH2 and SH3SH2 domain constructs, but we also got a signal in 
the negative control sample (Fig. 3.2b, red arrow). By analyzing the sequence of the negative 
control we found that it contains an additional sequence from multiple cloning site of the 
plasmid. We prepared its shorter version lacking most of this extra sequence. As illustrated 
in Fig. 3.2c and d, this modification decreased the non-specific interaction with Myc-EGFP-
SH2 construct, although it did not eliminated it entirely. In addition, we found out that SH2 
construct was able to bind to beads in the absence or presence of HA-RACK1 construct (Fig. 
3.2e), suggesting this binding is non-specific. 
 
9.1.5. In in-vitro translation and interaction reconstituting system 
 
Due to our inability to eliminate the non-specific interactions of SH2 construct with the 
beads, we decided to study the RACK1-Lck interaction in more controlled environment of in-
vitro translation procedure. We created a modular system for cloning any construct into a 
plasmid with 3xFLAG tag or GST tag under T7 promotor. We prepared 3xFLAG-SH3SH2, GST-
SH3SH2, GST-SH3, GST-SH2, 3xFLAG-RACK1, GST-RACK1, 3xFLAG-WD1-3 (first three WD40 
domains of RACK1) and 3xFLAG-WD4-7 (last four WD40 domains of RACK1). These 
constructs were then translated “in vitro” and the product of two or three translation 




Figure 3.3 Interaction of Lck and RACK1 in in-vitro translation system. Plasmids with T7 
promotor was used to cloned 3xFLAG-SH3SH2, GST-SH3SH2, GST-SH3, GST-SH2, 3xFLAG-
RACK1, GST-RACK1, 3xFLAG-WD1-3 (first three WD40 domains of RACK1) and 3xFLAG-
WD4-7 (last four WD40 domains of RACK1). In-vitro translations of 3xFLAG-SH3SH2 and GST-
RACK1 were loaded on anti-FLAG beads separately or together, let to interact and consequently 
stained, showing no specific interaction (a). The same experiment was performed in a reciprocal 
configuration, using 3xFLAG-RACK1 and GST-SH3SH2, again with the negative result (b). We then 
decided to test interaction of full-length Y505F Lck with 3xFLAG-RACK1, 3xFLAG-WD1-3 and 
3xFLAG-WD4-7. Increased interaction of RACK1 with WD1-3 can be observed, but it might be also 
non-specific nature (c). Several proteins can be detected to associate with RACK1 and change their 
phosphorylation status during T-cell activation as shown by RACK1 immunoprecipitation and 
subsequent staining with phosphotyrosine-specific antibody 4G10 (e). One of the interacting proteins 
has been shown to be adaptor protein GADS. We therefore tested GADS as possible mediator of 
interaction between RACK1 and Lck. The product of in vitro translation of Y505F Lck and GADS 
were mixed with either 3xFLAG-RACK1, or 3xFLAG-WD1-3 or 3xFLAG-WD4-7, and then 
immunoprecipitated using anti-GADS magnetic beads,. Bound proteins were then stained against 
FLAG, GADS and Lck (e). High non-specific background interactions of RACK1-derived proteins 
limit the sensitivity of detection. Despite these difficulties, the signal of RACK1 binding to GADS is 
increased over the control with only RACK1 on the beads. Faint bands with molecular size of Lck 
can be seen in samples containing both GADS and Lck, but due to its close proximity to a strong and 





Translation reactions containing 3xFLAG-SH3SH2 and GST-RACK1 were admixed, 
incubated with anti-FLAG beads and the amount of bound GST-RACK was assessed by 
western blotting. The amount of bound GST-RACK1 was comparable regardless of 3xFLAG-
SH3SH2 presence (Fig. 3.3a). This suggests that the binding of GST-RACK1 to the beads was 
of non-specific nature. The experiment was repeated in a reciprocal configuration, using 
3xFLAG-RACK1 and GST-SH3SH2 on anti-FLAG beads. No binding of GST-SH3SH2 could be 
detected in any sample (Fig. 3.3b). That would suggest that the involvement of Lck SH2 
domain in RACK1-Lck interaction is rather not direct. 
 
In the next experiment, we decided to use untagged constitutively active Y505F Lck for 
translation rather than its constructs containing only particular SH2 and/or SH3 domains. We 
expected that kinase active form of Lck in its full-length version would minimize the risk of 
faulty interaction caused by the excision of the SH domains from the full sequence. It will 
also better mimic the situation after the stimulation of T-cells when the kinase gets 
activated.  We also used 3xFLAG-WD1-3 and 3xFLAG-WD4-7 in addition to full 3xFLAG-
RACK1, as it has been shown that when separated, the particular moieties of RACK1 can bind 
their partners more potently then intact full-size RACK1 (Kouba et al., 2012). Unfortunately, 
these results were again inconclusive because of non-specific interactions that were present 
(Fig. 3.3c). Specifically, increased signal of Lck was observed when interacting with WD1-3. It 
is, however, unclear whether it is a sign of interaction or a sum of non-specific bands 
observed in unmixed Lck and WD1-3. 
Since we failed to obtain any convincing evidence in support of a direct interaction 
between Lck and RACK1, and the fact that at least three structural elements are involved in 
their complex formation, we proposed that RACK1 and Lck interaction was likely mediated 
by additional proteins present in the complex. In this context, Ondřej Ballek, a PhD student 
in our lab, demonstrated the presence of other proteins in RACK1-Lck complex. Notably, 
when he immunoprecipitated RACK1 complexes at various intervals after TCR triggering by 
TCR/CD4 aggregation, he could distinguish several proteins that dynamically changed their 
phosphorylation status (Fig. 3.3d). MS analysis of these immunoprecipitated proteins 
performed in the laboratory of Prof. Jiří Stulík (Institute of Molecular Pathology, Faculty of 
Military Health Sciences, Hradec Králové), identified them as α-actinin, GADS, LASP1 and 
α-tubulin. Because GADS is a well-known adaptor protein which has been previously 
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described to constitutively interact with RACK1 (Ellis et al., 2000), we decided to assess 
whether it could function as a linker between RACK1 and Lck. A construct containing GADS 
under control of T7 promoter was prepared. Then we translated GADS and Y505F Lck, mixed 
with translated 3xFLAG-RACK, 3xFLAG-WD1-3 or 3xFLAG-WD4-7, and performed IP GADS 
(Fig. 3.3e). Again, we encountered the problem with a high nonspecific background binding 
as in previous experiments. Thus, even though these data suggest that GADS interacts with 
RACK1 because the amount of pulled down RACK1 in the presence of GADS is somewhat 
higher that in its absence, no definite conclusions can be drawn. The same applies for the 
complex formation between RACK1-GADS and Lck. Notably, the faint band of Lck is seen in 
IPs containing GADS, Lck and all three RACK1-related constructs, but due to a strong signal 
from heavy chain of antibodies with a similar molecular weight, its relevance cannot be 
unambiguously interpreted. 
 
9.2. Adenovirus-mediated expression of RACK1 
 
Our next goal was to assess the physiological significance of RACK1 in the proximal TCR 
signalling and during the activation of primary T-cells. Because primary naïve T-cell are very 
hard to transfect, we decided to use TgCAR mouse strain expressing coxsackie/adenovirus 
receptor (CAR) under CD2/Lck promotor. The receptor is therefore expressed almost 
exclusively on T-cells. This ectopic receptor enables specific infection of naïve T-cells by 
adenovirus (Wan et al., 2000b). Another advantage of this mouse strain is also the fact that 
it expresses transgenic DO11.10 TCR specific for OVA323-339 peptide. T-cells isolated from 
these mice can therefore be activated by dendritic cells pulsed with this peptide. Infection 
by adenovirus enabled us to induce overexpression of RACK1 in naïve T-cells, which were 
then examined for changes in the activation mechanisms. We also created plasmids 
containing shRNA that will be used in future experiments for the production of viruses and 
subsequent downregulation of RACK1 in primary naïve T-cells. This part of my thesis was 
performed in close collaboration with Ondrej Ballek, where I assisted him in the preparation 






9.2.1. Virus preparation 
 
For its overexpression in T-cells, we used 
RACK1 construct tagged by HA for easier 
detection. We cloned it into shuttle 
plasmid vector containing two ubiquitin 
promoters, first controlling EGFP, the other 
HA-RACK (Fig. 3.4a). As the negative 
control, we used the shuttle plasmid 
without any gene cloned under the second 
promoter. Successful function of the 
plasmid was assessed by transient 
transfection into cells. The expression was 
dependent on the cell type used for 
transfection, as it was readily detectable 
only in HEK293T cells (Fig. 3.4b, c). Due to 
an unusual construction of the plasmid, we 
created the control vector for the 
assessment of function of both ubiquitin 
promoters. Specifically, in the multiple 
cloning site under second ubiquitin 
promoter we inserted the fluorescent  
Figure 3.4 Preparation of plasmid vectors for 
the generation of recombinant adenoviruses. 
For the preparation of adenoviruses we used the 
shuttle vector where EGFP and gene of interest 
is under the control of two separate ubiquitin 
promotors. (a). We inserted HA-RACK1 and 
tested expression of HA-RACK1 (b) and EGFP 
(c) in four types of cells. Only HEK293T could 
express the proteins. The properties of the two 
promotors were tested by cloning mCherry 
under the control of second promotor. First 
promotor was stronger, as mCherry expression 
appeared only in cells with a relatively high 







Figure 3.5 Preparation of adenovirus. After cloning of HA-RACK1 into the shuttle vector, it 
was used for the transformation of a special type of bacteria that mediate insertion of EGFP 
and HA-RACK1 into adenoviral genome by homologous recombination. The genome was then 
isolated, linearized and transfected into AD-293 cells. This packaging cell line is then used for 
the production and amplification of the virus, which is then harvested and used for the 









protein mCherry. The expression of both fluorescent probes was detected using FACS 
analysis. mCherry from the second promoter was expressed only when certain level of EGFP  
 
Figure 3.6 Optimalization of infection conditions. The adenoviral-mediated expression of 
GFP by the T-cells was rapidly decreasing over a few day period due to poor viability of 
cells. Within three days, GFP
+
 cells were virtually gone (a). To enhance viability, the 
medium was supplemented with IL-7 cytokine. Its amount was titrated (b) and 2 ng/ml was 
determined as the sufficient amount. The percentage of surviving GFP
+
 cells was 
significantly improved with addition of IL-7 (c). The amount of HA-RACK produced in the 
infected cells was dependent on multiplicity of infection (MOI) (d), although the production 
of EGFP was saturated even in low MOI (e). Increasing MOI caused impaired viability of 











expression from the preceding ubiquitin promoter was achieved, indicating that expression 
from the second promotor is relatively weak (Fig. 3.4d). 
 
In order to produce the virus causing desired expression level of RACK1, two separate 
shuttle plasmids with either HA-RACK1 or EGFP had to be inserted into the adenoviral 
genome (Fig. 3.5). For this purpose, we used the shuttle plasmid to cotransform bacteria 
with pAdEasy-1 vector, where they could recombine by homologous recombination (Fig. 
3.5). Adenoviral plasmids containing our transgenes were then isolated, linearized and 
Figure 3.7 Functional testing of HA-RACK1 overexpression. The infection by adenovirus 
coexpressing HA-RACK and EGFP or EGFP only (mock control) at MOI 5 caused enhanced the 
activation phenotype of T-cells, and the presence of HA-RACK had undistinguishable effect from 
that of the control sample. The early phase of activation was determined by the expression of 
CD69 and loss of CD62L expression; level of activation by both viruses was comparable (a). The 
second phase of activation was observed by production of CD25 after 24 and 48 hours. Activation 
after 24 hours was higher in cells infected by control virus, but no significant difference was 
detectable after 48 hours (b). The proliferation of the cells was measured after 72 hours, 




electroporated into AD-293 cells. AD293 cells are more adhesive version of HEK293 cells 
used specifically for the production and amplification of virus particles to desired viral titers.  
 
9.2.2. HA-RACK1 overexpression 
 
With the viruses ready, we had to optimize conditions for our experiments. Crucial is the 
survival of primary naïve T-cells for extended time.  For this purpose we decided to use 
antiapoptotic cytokine IL-7. Its optimal concentration was determined (Fig. 3.6b). The 
titration showed that 2 ng of IL-7 per ml of medium is sufficient to improve T-cells survival. 
 
Other important variable is multiplicity of infection (MOI), the mean number of virus 
particles in medium that could infect one cell. The amount of isolated virus particles was 
experimentally determined. Various MOI were then tested on the cells. After infection, the 
expression of GFP in surviving cells was observed for three consecutive days with or without 
IL-7 (Fig. 3.6c and a, respectively).  It is recommended to use MOI as low as possible, as the 
excess of virus particles can negatively affects cell survival. The experiment identified MOI 20 
as relatively low and yet providing sufficient expression of GFP.  
 
Next, we tested the production of HA-RACK1 on protein level in addition to GFP 
fluorescence and viability of the cells. With increasing MOI, the production of HA-RACK1 rose 
(Fig. 3.6d), although GFP fluorescence appeared to be saturated (Fig. 3.6e). However, the 
viability of cells was reversibly correlated with MOI used, ranging from 70 % live cells with 
MOI 5 to 40 % with MOI 100 (Fig. 3.6f). 
 
After determining optimal conditions for our experiments we proceeded to functional 
tests of T-cells infected by virus expressing either GFP, or HA-RACK1 or empty vector. CD4+T-
cells isolated from TgCAR mice were infected by the virus at MOI 5. Higher MOI caused 
spontaneous activation of the T-cells to the extent that it would prevent determination of 
effect of HA-RACK. After infection and incubation of T-cells, we mixed them with the bone 
marrow-derived dendritic cells pulsed with OVA peptide. We tested different stages of T-cell 
activation. First stage can be identified by changes in the expression of CD69 and CD62L after 
4 hours from activation. While non-activated T-cells express CD62L and not CD69, activated 
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T-cells show the opposite pattern. The 
portion of activated CD62L-CD69+ cells 
increased markedly in cultures with virus, 
but there was no difference whether the 
virus contained HA-RACK1 or not (Fig. 
3.7a). The second stage of activation was 
determined by expression of CD25 after 24 
and 48 hours (Fig. 3.7). We observed 
analogous situation, both viruses caused 
increased activation to extend disregarding 
virus type. The final step of activation is 
proliferation, which was detected by 
staining the cells with proliferation dye 
(Fig. 3.7c).  However, in conclusion no 
significant difference between GFP and HA-
RACK1 viruses could be observed.  
 
9.2.3. RACK1 knock-down 
 
The lack of observable effect of HA-
RACK1 overexpression could be explained by low level of HA-RACK1 expression compared to 
endogenous RACK1 (Fig. 3.6d). We therefore decided to try different approach, decreasing 
the amount of RACK1 rather than increasing it. To this end, four different shRNA have been 
designed by Ondřej Ballek. Their negative effect on RACK1 transcript and protein levels was 
confirmed in NIH3T3 fibroblast cell line by transfection (Fig. 3.8). The production of viruses 





Figure 3.8 Downregulation of RACK1 in 
NIH3T3 cells. Four different shRNAs were 
tested for their ability to downregulate RACK1 
in NIH3T3 cells. They were able to decrease the 
amount of RACK1 to levels ranging from 3 % 






T-cell activation is a complex process, and despite the extensive research conducted in 
this field some of its aspects remain poorly understood. One of them is the initiation of the 
most proximal TCR signalling and the mechanisms how the engagement of TCR is translated 
into a productive activation of Lck and delivery of its function. That includes the membrane 
redistribution of the main signaling components observed upon TCR triggering. Our previous 
work identified adaptor protein RACK1 as a candidate interaction partner involved in the 
activation-induced redistribution of Lck. In this thesis, we performed the structure-function 
analysis of RACK1-Lck interaction and assessed the functional consequences of RACK1 up- 
and downregulation of its gene expression. We examined our proposition that C-terminal tail 
of Lck functions as a novel regulator of protein-protein interactions with ability to affect the 
its targeting of downstream targets as well as its kinase activity. The premise of this 
investigation was that the C-terminal end of Lck plays a role in the interaction with adaptor 
protein RACK1 which mediates the activation-induced translocation of Lck into lipid rafts by 
the mechanism involving microtubular cytoskeleton. Such repartitioning of kinase active Lck 
to lipid rafts could result in the phosphorylation and activation of other members of the TCR 
signalling machinery and the initiation of T-cell activation process. Indeed, based on our 
previous results, we have suggested the Lck-dependent Fyn activation model where the 
activation of Lck and subsequent translocation to the lipid rafts leads to activation of raft-
resident Fyn and other downstream signalling proteins (Filipp et al., 2003). 
Our laboratory previously reported a negative influence of sequential truncations of the 
first half of C-terminal tail of Lck (ΔYQPQP) on global tyrosine phosphorylation status in cell 
SYF cells (Filipp et al., 2008). Results associated with this experiment showed a gradual 
diminishment of Lck to interact with RACK1 and to phosphorylate its intracellular targets, 
culminating in the complete ablation of phosphorylation with ΔYQPQP Lck. Yet, the kinase 
activity of Lck itself was comparable or reduced to only 50% compared to the WT Lck. 
However, natural and recombinant Lck mutants lacking the C-terminal end are fully active as 
the inhibitory binding of SH2 domain to its own pY505 does not occur. Thus, in presented 
work, we extended the set of the truncation mutants to gradually cover the entire tail 
sequence of Lck and expected that the negative effect of these truncations on RACK1 
interaction and phosphorylation of target proteins will be reversed.  
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When the complete panel of these truncations was examined, different results were 
obtained compared to those published previously (Filipp et al., 2008). Specifically, all Lck 
truncation mutants, including ΔYQPQP and ΔC11, displayed comparable levels of tyrosine 
phosphorylation of many intracellular proteins in comparison to that of the constitutively 
active Y505F Lck, the template of which was used for the generation of these truncations 
(Filipp et al., 2008). Thus, we failed to confirm the previously published results. New results 
showed consistent levels of global tyrosine phosphorylation (Fig. 1d).  Possible explanation 
for this discrepancy could lay in mutation found in ΔYQPQP truncate causing this negative 
effect.  Our newly generated ΔYQPQP construct behaved as the constitutively active Y505F 
Lck. Another explanation can be the unfavourable integration site of the retrovirus which 
could intercalate into a part of genome that would silence the transgene.  
Of note is also the loss of tyrosine phosphorylation in cells with Lck with mutated SH2 
domain (R154K). In the original experiment (Filipp et al., 2008), this mutant showed high 
levels of global phosphorylation, which is consistent with the fact that proper function of 
both SH2 and SH3 domains is necessary for effective Lck inhibition (Cowan-Jacob et al., 
2005). Our current experiment showed completely opposite results as R154K Lck containing 
cells lacked the phosphotyrosine signals almost entirely. At this moment, the reason for such 
discrepancy is not known, but the verification of the sequence of the previously and 
currently used SH2 Lck mutant construct will be performed in a very near future to confirm 
or disapprove their identity.  
The main reason for the creation of C-terminus truncates was to verify the hypothesis 
that this part of Lck contributes to the translocation of Lck to lipid rafts via association with 
RACK1. This assumption was supported by the fact that QP-based C-terminal sequence has 
been shown to affect localization in lipid rafts (Navratil et al., 2006). A decrease in the 
interaction of RACK1 with ΔC11 (Fig. 1c) (Ballek, 2009) and ΔYQPQP Lck (Ballek, unpublished 
data) was also observed before. The immunoprecipitation of Lck truncates with RACK1, 
however, showed only a limited influence of the C-terminal truncation on the amount of Lck 
associated with RACK1. That specifically concerns the ΔC9 Lck truncate, which displayed 
approximately a 50% reduction in the complex formation with RACK1 compared to other Lck 
mutants. While these experiments suggest that Lck-RACK1 interaction can be affected by the 
C-terminal end of the former, the mechanism and conditions under which it occurs remain 
to be determined in the future. 
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Marked decrease in the interaction was also clear in mutants with inactive SH2 and SH3 
domains as well as in Y394F, kinase inactive Lck with mutation in the activatory tyrosine 
positioned in the activatory kinase loop. Interestingly, the interaction of another kinase 
inactive Lck, K273A, with RACK1 was not impaired, which suggests that this interaction is 
independent of the kinase activity. While the K273 is a part of the N-lobe of the kinase 
domain and is located inside the catalytic cleft where it coordinates the phosphate group of 
ATP and helps to stabilize the proper position of the C helix, the Y394 is located on C-lobe 
and its phosphorylation leads to the reorganization of the activation loop, creating a 
substrate-binding surface on the opening of the catalytic cleft (Xu et al., 1997). It is possible 
that this latter surface, accessible to other proteins, is by some unknown mechanism 
involved in the interaction with RACK1. In this context, it remains to be determined the level 
of pY394 in K273 Lck mutant to exclude or consider the possibility that this phosphorylated 
residue could be involved in interaction with RACK1. 
Although we showed that Lck interacts with RACK1, details of this interaction remained 
largely uncharacterized. We tested whether the interaction was direct, and if so, whether it 
was mediated by one or both SH domains. RACK1 contains 6 tyrosines that can be 
phosphorylated and therefore can serve as a binding site for SH2 domains. It was described 
that Src binds to pTyr246 of RACK1 (Chang et al., 2001), but interaction with Lck has not 
been mechanistically described. We were unable to detect specific interaction of any SH 
domain with RACK1, as the detected binding of SH2 turned out to be nonspecific. Even after 
transferring these experiments to a cell-free system, detected interactions were of non-
specific nature or largely inconclusive. The proteins were binding to the beads without the 
presence of the immunoprecipitated protein, and in the case of magnetic beads, regardless 
of the presence or absence of precoated antibody (data not shown). Additionally, the 
detection of precipitated proteins was problematic and required unusually long exposures of 
the film. The most likely explanation is a very low level of bound protein or insufficient 
antibody binding. 
The fact that mutations in both SH2 and SH3 (and in previous experiments also truncated 
C-terminus) caused partial, but not complete, loss of interaction with RACK1 suggests that 
the complex translocated to lipid rafts upon activation could consist of multiple proteins. At 
least some of these additional proteins are susceptible to tyrosine phosphorylation and their 
phosphorylation proceeds rapidly during T-cell activation (Fig. 3d). The number of proteins 
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detected in these complexes by phosphotyrosine-specific antibody also favours the idea of 
larger multiprotein complex translocation. 
This finding is also consistent with the fact that only high molecular weight complexes 
containing Lck are able to translocate to lipid rafts upon activation (Ballek et al., 2012). The 
complexes were divided according to its size by gel filtration. The comparison of samples 
from T-cells activated for 30 seconds and non-activated ones showed that high molecular 
weight fractions exclusively participated in Lck redistribution. Furthermore, active Lck 
(phosphorylated on Tyr394) can be found exclusively in high molecular weight complexes.  
Further analysis of the behaviour of the complexes showed that their translocation to lipid 
rafts relies on the microtubular network, rather than actin or vimentin filaments. Specifically, 
the addition of nocodazol to T-cells abolished translocation of the high molecular weight 
complexes to lipid rafts, while latrunculin B displayed no such effect (Ballek et al., 2012). The 
utilization of microtubule network in the translocation event is further supported by the fact 
that the MS analysis of RACK1 immunoprecipitates found α-tubulin present. With additional 
proteins such as α-actinin, LASP and GADS identified as a part of RACK1-Lck complex, its 
precise multiprotein organization and kinetics of its formation remains to be elucidated.  
At least for now, the question how the interaction of Lck and RACK1 is mediated remains 
unanswered. As an adaptor protein which interacts with RACK1 directly and constitutively 
(Ellis et al., 2000), GADS could be the missing element mediating RACK1-Lck interaction. We 
therefore tried to reconstitute the possible core formation of the complex by coincubating 
these three proteins or their moieties which were produced by in-vitro translation and to 
pull down the complex (Fig. 3e). Unfortunately, due to a high background nonspecific 
binding, we were unable to detect complex formation between RACK1-GADS-Lck. We only 
detected an increase in the amount of RACK1 bound to anti-GADS-precoated beads in the 
presence of GADS protein over that determined in the absence of GADS. However, this 
would just confirm the previously reported binding of RACK1 with GADS. Definitely, more 
experiments are needed to work out the precise conditions and the protein composition of 
this complex. Additional proteins are very likely to be required in the mixture to form this 
multiprotein complex. Other intriguing possibility is that the RACK1-Lck complex formation 
can occur only in the presence of microtubular network or other cytoskeletal components 
and thus, the assembly of this complex in in vitro conditions is experimentally unattainable. 
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We would also like to make several technical comments. First, in the immunoprecipitation 
experiments we switched from agarose to magnetic beads because the agarose beads have 
a large internal surface, while magnetic beads bind proteins only on the outside surface of 
the beads. We hoped that this fact would lead to decrease in a non-specific protein binding. 
Unfortunately, this was not the case, as constructs derived from RACK1 were still bound to 
the beads even in the absence of GADS which should mediate this interaction. The same was 
observed when no anti-GADS antibody was used to precoat the beads. Under such 
conditions, if the RACK1-GADS interaction indeed occurs but is of weak nature, it is likely 
masked by a non-specific binding, precluding us to make any reasonable conclusion. Second, 
for the detection of the proteins, we used fluorescent WB imaging. This method enables 
observing two distinct proteins on a single blot; the whole sample can therefore be loaded 
on one gel rather than split on two, and even the weaker signal can be reliably detected. In 
our case, however, the fluorescent secondary antibodies caused high background by staining 
heavy chains of the antibodies used for the immunoprecipitation. As the heavy chain signal, 
which is usually very strong and “fat”, is of similar molecular weight as Lck, it extend to the 
area where Lck is detected, thus interfering  with its detection. A faint band corresponding 
to the size of Lck can be observed in samples containing recombinant GADS, RACK1 and Lck, 
but it is difficult to verify its identity. Third, as these pulldown experiments with three 
recombinant constructs contain the triple amount of these products compared to their 
individual control samples, non-specific binding cannot be ruled out. As discussed above, it 
would be maybe naïve to assume that mixing RACK1, Lck and GADS together, they start to 
form a biochemically detectable complex. The process could be much more complicated 
involving more structural components and of highly transient nature. Thus, even though we 
consider it likely that GADS, RACK1 and Lck are critical components of this complex, they are 
likely not sufficient to form its core capable of translocation of Lck to the lipid rafts. 
Additional components of the complex will have to be carefully examined to elucidate the 
interplay between the proteins involved in this translocation mechanism. 
We also tried to examine the physiological role of RACK1 in T-cell activation. The main 
idea was to change the level of RACK1 expression in primary naïve T-cells isolated from 
lymph nodes on the protein level and determine the effect on Lck translocation and early T-
cell response. We first used HA-RACK1 construct with a prospect to express of functional 
mutants of RACK1, should the system prove effective. However, using a relatively low MOI, 
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we were only able to induce a very mild overexpression of RACK1 over its endogenous 
counterpart with little tangible effect on T-cell proximal signalling (Fig. 7). Higher MOI led to 
the higher level of HA-RACK1 expression, but even with MOI 100, the amount of HA-RACK1 
did not reach its endogenous levels. Additionally, high MOIs of a mock only GFP-containing 
construct reduced the viability of the T-cells and caused their spontaneous activation to the 
extent where its effect became undistinguishable from that promoted by HA-RACK1 
recombinant construct, thus preventing us from reaching any conclusion about its 
physiological function. The likely cause for only a marginal increase in the expression of HA-
RACK1 could be that endogenous RACK1 is abundantly expressed protein and a robust 
expression with recombinant construct using adenoviral expression system is at this moment 
unachievable.  In addition, a massive overexpression of RACK1 is not well tolerated by at 
least some target cells, such as fibroblast, and leads to their sudden apoptosis (Tomáš 
Vomastek, personal comunication). 
In light of these results, the opposite approach, the downregulation of endogenous 
RACK1, seems to be a more appropriate and promising way of determining the function of 
RACK1 during T-cell activation. Our pilot experiments with shRNA-mediated knock-down of 
RACK1 in cell lines are encouraging, as various shRNAs are able to decrease the production 
of endogenous RACK1 to 3-27 % of its levels in untreated cells (Fig. 8). However, it is also 
likely that the inhibition will not be as effective in the primary T-cells. Immortalized NIH3T3 
cells grow continuously, divide and therefore have a very active metabolism. On the other 
hand, naïve T-cells are quiescent type of cells which resist division until they get activated. 
Due to this slower turnover of RNA synthesis and protein production, it will take them longer 
to diminish or deplete intracellular RACK1. Another aspect of this RACK1 downregulation 
experiment is the survival of T-cells. The fact that RACK1 knock-out is embryonically lethal 
(Volta et al., 2013) and RACK1 itself is required for the ribosome assembly and the initiation 
of translation, casts doubt whether downregulation of RACK1 is compatible with cell 
survival.  Our experiments with cell lines with downregulated RACK1 however suggest that 
cells can survival for several days even with severely decreased level of RACK1. While the 
experiments with RACK1 downregulation have not been completed, we prepared all 
necessary reagents, target cells, virion particles, tested the methodology and protocols for 
successful accomplishment of this task in the near future. 
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Taken together, we performed numerous experiments in order to perform the structure-
function analysis of RACK1-Lck interaction which seems to be a prerequisite for TCR-induced 
translocation of Lck to lipid rafts. On this experimental journey, we obtained several very 
encouraging results and prepare a whole battery of reagents which are necessary for further 
advancement of this project. As it usually happens with a new type of project like this, we 
also faced many technical difficulties which hold us back from determining the precise 
mechanisms of complex formation between RACK1 and Lck and how RACK1 mediates Lck 
redistribution. It is likely that the role of RACK1 in T-cell signalling is similar to its function in 
other signalling pathways, where it mediates the intracellular relocalization of other effector 
signalling proteins. Even though we detected the interaction between RACK1 and Lck and 
identified SH2 and SH3 domains as important structural components required for their 
complex formation, we were unable to show how these interacting structures assemble 
together. We also cannot rule out that C-terminal tail of Lck has some role in this complex 
formation; however its impact on global tyrosine phosphorylation and interaction with 
RACK1 is less profound than originally expected. Moreover, our experiments strongly 
suggest that Lck does not bind RACK1 directly, but rather through several intermediary 
products. At least some of them were identified in this work and includes α-actinin, LASP, α-
tubulin and GADS. We showed that adaptor protein GADS is not sufficient to mediate 
interaction between RACK1 and Lck, at least under experimental conditions used in here. 
Unfortunately, our data concerning the functional role of RACK1 in activation of T-cells are 
inconclusive, but additional experiments are already underway. It is clear that while our 
work provided important information concerning the mechanism of Lck redistribution during 
early T-cell activation, much more research has to be performed on this new and interesting 






 SH2 and SH3 domains of Lck play a critical role in the complex formation with RACK1. 
 The C-terminal truncation of Lck exerted only a mild and sequence-specific effect on 
the RACK1-Lck complex formation. Specifically, last 9 aminoacid truncation of the C-
terminus of Lck decreases its interaction with RACK1, other truncates were 
ineffective. 
 The interaction between RACK1 and Lck is most likely to be indirect, mediated by 
other proteins. Several of these proteins were identified. Their involvement in the 
formation of RACK1-Lck complex has to be further evaluated. One of these proteins, 
the adaptor protein GADS, is unable to mediate this interaction. 
 Adenovirus mediated overexpression of RACK1 in primary T-cells failed to produce 
sufficient levels of RACK1 protein to assess its effect on T-cell activation process. 
Moreover, the viral infection of T-cells caused unspecific activation of these cells 
which precluded us from performing intended functional tests. 
 For an alternative approach, all reagents necessary for the downregulation of RACK1 
by RNA interference has been prepared and tested and will be used for the 
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